Swedish Diagnostics Firm Immunovia Moving US HQ From Boston To Durham

By Jim Shamp

Immunovia, a leading cancer diagnostics developer, is making a strategic move by relocating its North American headquarters to North Carolina's Research Triangle area. The decision aims to enhance efficiency and effectiveness in their operations. Immunovia's primary focus is on early diagnosis of pancreatic cancer through a blood-based system. They have recently launched a new, more accurate pancreatic cancer diagnostic that is also faster and more cost-effective. With the US being the largest market for pancreatic cancer detection, Immunovia aims to improve survival rates by offering a simple blood test for early detection. Continue reading to learn more.